Pick Up This Deal Even Lower Than Director McIlwraith Did

There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on November 6, Meridian Bioscience Inc.'s Director, John McIlwraith, invested $20,187.00 into 1,000 shares of VIVO, for a cost per share of $20.19..